Aether Industri.
Aether Industri. Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 4 strong
The short version
CEM (Contract Exclusive Manufacturing) and CRAMS (Contract Research and Manufacturing Services) are expected to contribute over 70% of revenue in the next couple of years, indicating strong growth in these high-margin segments. Aether expects continued strong growth with expanding Contract Exclusive Manufacturing (CEM) and CRAMS models, aiming for these two segments to contribute over 70% of revenue in the next couple of years.
From Aether Industri.'s Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- CEM (Contract Exclusive Manufacturing) and CRAMS (Contract Research and Manufacturing Services) are expected to contribute over 70% of revenue in the next couple of years, indicating strong growth in these high-margin segments.
- Site 3++ block ramp-up and Site 5 commissioning are on schedule, which will increase production capacity and sales in upcoming quarters.
- New customer onboarding and more than nine customer audits cleared in Q1 FY27 signal a strong and growing order pipeline.
- Organic growth in the oil and gas segment, which already accounts for around 20% of revenue and expected to increase further.
- Semiconductor and material science segments have high growth potential with multiyear R&D programs underway, including new product commercialization starting Q2 FY27.
2 more points from Aether Industri.'s call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Aether Industri. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Total capex for Q1 FY27 was INR 943 million.
- Capex expected for FY27 is between INR 3,000 million to INR 3,500 million.
- FY27 capex primarily allocated to Site 5 and the new R&D site, which is progressing well.
- Expansion includes Site 3++ ramp-up and capacity scaling at Site 5.
- Strategic investments include building manufacturing capacity near Surat at Panoli (Magnum Site 5).
- Focus on concurrent expansions in R&D, pilot plants, and manufacturing assets.
2 more points from Aether Industri.'s call on capex
Pro opens every point from 15K+ earnings calls
Fundraising & Capital Structure
See what Aether Industri. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company does not disclose detailed order book or product count for competitive reasons at this stage. (Page 14)
- Commercial sales for new LSM products at Site 5 started in Q1 FY27, with revenue contribution expected from Q2 FY27. (Page 14)
- Order buildup is in progress for new LSM products across pharmaceutical, agrochemical, and material science sectors. (Page 14)
2 more points from Aether Industri.'s call on order book
Pro opens every point from 15K+ earnings calls
Aether Industri. — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹305 Cr, net profit ₹54 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Aether Industries Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Devson Catalyst Ltd (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Thirumalai Chem. (Q1 FY27)
Consolidated Revenue from Operations: INR 547 Cr (22% YoY increase from INR 450 Cr in Q1 FY26) . Key investor presentation takeaways from Thirumalai Chemicals L
- Neochem Bio (Q1 FY27)
Revenue from Operations in H2 FY26: ₹64.9 crore . Key investor presentation takeaways from Neochem Bio's Q1 FY27 investor presentation — and how it ranks agains
- Lords Chloro (Q1 FY27)
106.34 crore, a 6.88% YoY increase from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q1 FY27 investor presentation — and how it ranks
Arthneeti Pro · Annual
Aether Industri. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Aether Industri. Q1 FY27 results?
CEM (Contract Exclusive Manufacturing) and CRAMS (Contract Research and Manufacturing Services) are expected to contribute over 70% of revenue in the next couple of years, indicating strong growth in these high-margin segments. Aether expects continued strong growth with expanding Contract Exclusive Manufacturing (CEM) and CRAMS models, aiming for these two segments to contribute over 70% of revenue in the next couple of years.
What is Aether Industri. share price analysis?
Aether Industri. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 85.1 with a market cap of ₹20,422 Cr. Investors should review the full earnings analysis for detailed insights.
Is Aether Industri. planning capital expenditure?
Total capex for Q1 FY27 was INR 943 million.
Keep Aether Industri. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.